Dr. Loïc Laplanche
InvestorChief Operating Officer (COO), BIODOL Therapeutics at V-Bio Ventures
About
Dr. Loïc Laplanche, Ph.D., has more than 25 years of experience in non-clinical and translational sciences across discovery, preclinical, and clinical development in global pharmaceutical companies. He most recently held the role of Senior Scientific Director at AbbVie, where he led DMPK and regulated bioanalysis functions and contributed to non-clinical portfolio strategy in neuroscience, immunology, and oncology. He previously worked as a researcher at Sanofi-Aventis and led projects in several EU-IMI consortia, with expertise in non-clinical development and quantitative and translational pharmacology.
Colleagues at V-Bio Ventures
Aurelie Nowack
Principal at V-Bio Ventures
Charles Margarit
Associate at V-Bio Ventures
Christina Takke
Managing Partner at V-Bio Ventures
Dennis Pedri
Analyst at V-Bio Ventures
Dr. Marie-Laurence Gourlay-Chu
Chief Medical Officer at V-Bio Ventures
Katja Rosenkranz
Partner at V-Bio Ventures
Martin Solleveld
Finance Manager at V-Bio Ventures
Mathias Falcenberg
Venture Partner at V-Bio Ventures



